The impact of newer biological disease modifying anti-rheumatic drugs on cardiovascular risk factors: A 12-month longitudinal study in rheumatoid arthritis patients treated with rituximab, abatacept and tociliziumab

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Provan, Sella Aarrestad ^a   Berg, Inger Jorid ^a   Hammer, Hilde Berner ^a   Mathiessen, Alexander ^a   Kvien, Tore Kristian ^a   Semb, Anne Grete ^a  

^a DIAKONHJEMMET HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; CHOLESTEROL; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RITUXIMAB; TOCILIZUMAB; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DRUG EFFICACY; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MALE; OBSERVATIONAL STUDY; OPEN STUDY; PREDICTION; PROSPECTIVE STUDY; PULSE WAVE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK REDUCTION; TREATMENT DURATION; ARTHRITIS, RHEUMATOID; BLOOD; CARDIOVASCULAR DISEASES; DRUG EFFECTS; MIDDLE AGED; RISK FACTOR;

ABATACEPT; ADULT; AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULSE WAVE ANALYSIS; RISK FACTORS; RITUXIMAB; VASCULAR STIFFNESS;

EID: 84938537194     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130709     Document Type: Article

References (18)

1. Zhang J, Chen L, Deelzell E, Munther P, Hillegass W.B, Safford M, et al. The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 2014; 73 (7):1301-1308. doi: 10.1136/annrheumdis-2013-204715 PMID: 24796336
2. Wong M, Oakley SP, Young L, Jiang B, Wierzbicki AS, Panayi G, et al. Infliximab improves vascular stiffness in patients with rheumatoid arthritis. Ann Rheum Dis 2009; 68:1277-84 doi: 10.1136/ard.2007.086157 PMID: 18930987
3. Angel K, Provan SA, Fagerhol MK, Mowinckel P, Kvien TK, Atar D. Effect of 1-year anti-TNF-alpha therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study. Am J Hypertens 2012; 25(6):644-50. doi: 10.1038/ajh.2012.12 PMID: 22378036
4. Semb AG, Kvien TK, Aastveit AH, Jungner I, Pedersen TR, Walldius G, et al. Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study. Ann Rheum Dis 2010; 69:1996-2001. doi: 10.1136/ard.2009.126128 PMID: 20551156
5. Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, et al. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum 2006; 54(9):2793-806. PMID: 16947627
6. Kremer JM, Dougados M, Emery P, Durez P, Sibilia J, Shergy W, et al. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, doubleblind, randomized, placebo-controlled trial. Arthritis Rheum 2005; 52(8):2263-71. PMID: 16052582
7. Nishimoto N, Yoshizaki K, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, et al. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebocontrolled trial. Arthritis Rheum 2004; 50(6):1761-9. PMID: 15188351
8. Fransen J, Creemers MC, van Riel PL. Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology (Oxford) 2004; 43 (10):1252-5. PMID: 15238643
9. Backhaus M, Burmester GR, Gerber T, Grassi W, Machold KP, Swen WA, et al. Guidelines for musculoskeletal ultrasound in rheumatology. Ann Rheum Dis 2001; 60(7):641-9. PMID: 11406516
10. Provan SA, Semb AG, Hisdal J, Stranden E, Agewall S, Dagfinrud H, et al. Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study. Ann Rheum Dis 2011; 70(5):812-7. doi: 10.1136/ard.2010.141523 PMID: 21288959
11. Kume K, Amano K, Yamada S, Hatta K, Ohta H, Kuwaba N. Tocilizumab monotherapy reduces arterial stiffness as effectively as etanercept or adalimumab monotherapy in rheumatoid arthritis: an open-label randomized controlled trial. J Rheumatol 2011; 38(10):2169-71. doi: 10.3899/jrheum.110340 PMID: 21807781
12. Vlachopoulos C, Dima I, Aznaouridis K, Vasiliadou C, Ioakeimidis N, Aggeli C, et al. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation 2005; 112(14):2193-200. PMID: 16186422
13. Mathieu S, Couderc M, Glace B, Pereira B, Tournadre A, Dubost JJ, et al. Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis. Biologics 2013; 7:259-64. doi: 10.2147/BTT.S52003 PMID: 24324327
14. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005; 46(9):1753-60. PMID: 16256881
15. Mathieu S, Pereira B, Dubost JJ, Lusson JR, Soubrier M. No significant change in arterial stiffness in RA after 6 months and 1 year of rituximab treatment. Rheumatology (Oxford) 2012; 51(6):1107-11. doi: 10.1093/rheumatology/kes006 PMID: 22328565
16. Kerekes G, Soltesz P, Der H, Veres K, Szabo Z, Vegvari A, et al. Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis. Clin Rheumatol 2009; 28(6):705-10. doi: 10.1007/s10067-009-1095-1 PMID: 19319624
17. Gonzalez-Juanatey C, Llorca J, Vazquez-Rodriguez TR, Diaz-Varela N, Garcia-Quiroga H, Gonzalez-Gay MA. Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy. Arthritis Rheum 2008; 59(12):1821-4. doi: 10.1002/art.24308 PMID: 19035415
18. Hammer HB, Sveinsson M, Kongtorp AK, Kvien TK. A 78-joints ultrasonographic assessment is associated with clinical assessments and is highly responsive to improvement in a longitudinal study of patients with rheumatoid arthritis starting adalimumab treatment. Ann Rheum Dis 2010; 69(7):1349-51. doi: 10.1136/ard.2009.126995 PMID: 20472599